Introduction
Aim
Materials and methods
Patient number | Age | Diagnosis | Sessions*
| Adverse events | Postoperative pain (VAS, mm) measured in the 7 days following the first session (medication used) | Follow-up**
|
---|---|---|---|---|---|---|
1 | 24 | Chronic tonsillitis | 1 | / | 20 | 24 months/Improved symptoms |
2 | 57 | Hypertrophic tonsillitis | 2 | Moderate sore throat | 10 | 18 months/Complete recovery |
3 | 34 | Recurrent tonsillitis | 3 | Moderate burning and local swelling persisting for 24 h | 20 | 36 months/Complete recovery |
4 | 37 | Chronic pharyngotonsillitis | 3 | / | 25 | 16 months/Improved symptoms |
5 | 26 | Relapsing acute tonsillitis | 1 | / | 5 | 21 months/Complete recovery |
6 | 27 | Tonsil remnants with infections | 2 | / | 15 | 24 months/Complete recovery |
7 | 24 | Tonsillar hypertrophy and infections | 1 | Moderate oedema | 20 | 16 months/Complete recovery |
8 | 56 | Recurrent tonsillitis | 1 | Moderate burning persisting for 48 h | 40 (Diclofenac 100 mg capsules [2 times/day for 3 days; IBSA, Lugano, Switzerland]) | 21 months/Complete recovery |
9 | 21 | Relapsing tonsillitis and tonsillar hypertrophy | 1 | Moderate exudate | 30 (Naprosyn 750 mg capsules, [2 times/day for 3 days; Recordati, Italy]) | 20 months/Complete recovery |
10 | 6 | Tonsillar hypertrophy | 2 | Moderate pain and dysphagia | 20 (ice) | 24 months /Complete recovery |
11 | 32 | Pyogenic tonsil remnants | 2 | Pain and scanty blood spots | 40 (Tranex, 500 mg/5 ml ampoules [2 times/day for 1 day; Malesci Istituto Farmacobiologico, Bagno a Ripoli, Italy], Contramal 100 mg capsules [1/day for a day; Formenti, Milan, Italy]) | 20 months/Complete recovery |
12 | 51 | Tonsillar hypertrophy and relapsing tonsillitis | 1 | Burning and pruritus | 20 (ice) | 18 months/ Complete recovery |
13 | 19 | Relapsing tonsillitis and laryngitis | 2 | Moderate discomfort and dryness | 15 (Ephynal 300 mg capsules [3 times/day for 2 weeks; Abiogen Pharma, Pisa, Italy] and ice) | 15 months/Improved symptoms |
14 | 63 | Post-viral tonsillar hypertrophy | 1 | / | 5 | 19 months/ Improved symptoms |
15 | 34 | Chronic tonsillitis | 1 | Moderate discomfort and cough | 20 (ice) | 12 months/Improved symptoms |
16 | 44 | Tonsillitis and tonsillar hypertrophy | 2 | / | 30 (Toradol 30 mg/ml ampoules [1/day for 2 days; Rome, Italy]) | 18 months/Complete recovery |
17 | 43 | Chronic fibrinous tonsillitis | 1 | Some transient dysphagia | 25 (ice) | 14 months/Improved symptoms but one replapsing episode was observed |
18 | 59 | Acute relapsing tonsillitis | 1 | Sore throat | 10 | 18 months/Complete recovery |
19 | 34 | Tonsillar hypertrophy and rheumatic fever | 1 | Slight oedema and swallowing burns | 25 (local Xentafid 0.13 % [3 times/day for 5 days; Fidia Farmaceutici, Abano Terme, Italy] and ice) | 24 months/Complete recovery |
20 | 21 | Waldeyer’s hypertrophy and tonsillar culture positive for Streptococcus viridians | 2 | Inflammation of the pharynx | 35 (Augmentin 375 mg tablets [2 times/day for 3 days; GlaxoSmithKline, Verona, Italy]) | 24 months/Improved symptoms but one replapsing episode was observed |